UroMonitor Wins 1st Place in M2D2 $200K Competition

View as a webpage

UroMonitor Wins 1st Place in M2D2 $200K Competition


The UroMonitor, a flexible, durable, and biocompatible device that wirelessly transmits bladder data without catheters to improve the diagnosis and treatment of urinary incontinence & voiding dysfunction, was one of five 1st place winners in the worldwide 8th annual M2D2 $200K Challenge, receiving $25k of in-kind funding from Hologic.

In a change from previous years, the winners were grouped into tiers for first, second, and third places to recognize every winning innovation in the most appropriate manner.

A new record was set with over 150 applications and the 19 finalists, all presenting early-stage medical device, diagnostic, and biotech innovations, were eligible for a share of $200,000 in sponsor-provided, in-kind services, including lab and office space, engineering, product development, legal, regulatory, clinical, and business services.

Example of the Uromonitor

All finalists displayed and demonstrated their ideas at the M2D2 Challenge Finalist Pitch-Off on March 27 at University of Massachusetts Lowell’s University Crossing and the Challenge winners were announced on April 10.

Development and testing of the UroMonitor is a joint project between APT Center, Cleveland Clinic, and Parker Hannifin, taking advantage of the capabilities of all three institutions. To learn more about the UroMonitor, read an interview with Margot Damaser, PhD, who leads the UroMonitor project at the APT Center and at Cleveland Clinic Lerner Research Institute Department of Biomedical Engineering, or watch her presentation at the M2D2 Challenge.